Eaton Vance Management’s bluebird bio BLUE Stock Holding History

Eaton Vance Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25	Closed	-$5K	–	1910
2021 Q4	$5K	Sell	25 -14	-36%	-$3.3K	﹤0.01%	2630
2021 Q3	$10K	Hold	39	–	–	﹤0.01%	1727
2021 Q2	$16K	Sell	39 -4	-9%	-$1.58K	﹤0.01%	2464
2021 Q1	$17K	Buy	+43	New	+$21.2K	﹤0.01%	2141
2020 Q1	–	Sell	-6,013	Closed	-$6.83M	–	1308
2019 Q4	$6.83M	Sell	6,013 -12,229	-67%	-$13.3M	0.01%	539
2019 Q3	$21.7M	Sell	18,242 -1,479	-7%	-$2.26M	0.05%	294
2019 Q2	$32.5M	Buy	19,721 +16,342	+484%	+$28.3M	0.07%	247
2019 Q1	$6.89M	Buy	3,379 +1,640	+94%	+$2.89M	0.02%	494
2018 Q4	$2.23M	Buy	1,739 +625	+56%	+$959K	0.01%	698
2018 Q3	$2.11M	Hold	1,114	–	–	﹤0.01%	750
2018 Q2	$2.27M	Buy	+1,114	New	+$2.54M	0.01%	708

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Eaton Vance Management's BLUE Position: Q1 2022 in Review

Eaton Vance Management sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 25 shares — an estimated $5K sold.

Eaton Vance Management first reported a position in BLUE in Q2 2018 and held it in 11 quarters. The position peaked at $32.5M in Q2 2019. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

Eaton Vance Management reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
Eaton Vance Management sold 25 bluebird bio shares in Q1 2022, an estimated $5K.
Eaton Vance Management first reported a position in bluebird bio in Q2 2018 and held it in 11 quarters.
Eaton Vance Management's bluebird bio position peaked at $32.5M in Q2 2019.
174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.